Carey Stephen P.'s Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Aug 16, 2023
- Accession no.
- 0001674236-23-000004
- Filed
- Aug 16, 2023
- Trade date
- Aug 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.08M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carey Stephen P.CIK 0001674236 | Officer (SVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Common Stock | SSaleDisposed | −17,639 | $61.37F1 | −$1,082,505.43 | 155,839 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.50 to $61.86, inclusive.
Referenced by the price of 1 transaction in Table I.